Zheng, Song <br/><br/>
KIT and BRAF heterogeneous mutations in gastrointestinal stromal tumors after secondary imatinib resistance.  [electronic resource] 

 -  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association  Oct 2015 
 - 796-802 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1436-3305 
<br/><br/><label>Standard No.: </label>10.1007/s10120-014-0414-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Blotting, Western<br/>Cell Transdifferentiation--genetics<br/>Chromatography, High Pressure Liquid<br/>DNA Mutational Analysis<br/>Drug Resistance, Neoplasm--genetics<br/>Gastrointestinal Stromal Tumors--drug therapy<br/>Humans<br/>Imatinib Mesylate--therapeutic use<br/>Immunohistochemistry<br/>Male<br/>Mutation<br/>Neoplasm Recurrence, Local--genetics<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Proto-Oncogene Proteins c-kit--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Stomach Neoplasms--drug therapy